We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

CTI Acquires Mirada Solutions

By HospiMedica staff writers
Posted on 12 Sep 2003
In a move to enhance the company's positron emission tomography (PET) systems, CTI Molecular Imaging, Inc. (Knoxville, TN, USA) has acquired Mirada Solutions Limited (Oxford, UK). Terms were not disclosed.

Mirada, a spinoff from Oxford University, is a developer of fusion software applications for medical imaging workstations. CTI plans to incorporate Mirada's image analysis and fusion software into all its PET scanner workstations, to enhance the analytical and diagnostic capabilities of its PET systems. Mirada has developed several products designed to provide better detection, diagnosis, and disease management through the application of image analysis software to medical images.

"We believe that we have acquired the best-in-class capability that will further distinguish our PET scanners in the marketplace,” said Terry Douglas, chairman and CEO of CTI. "With this acquisition, we not only offer the fastest scan time through our proprietary LSO technology, but we also provide the greatest level of PET image functionality for the clinician.”





Related Links:
CTI
Mirada
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

Surgical Techniques

view channel
Image: Associate Professor Vi-Khanh Truong and Dr. Ngoc Huu Nguyen at the Flinders University Biomedical Nanoengineering Laboratory (Photo courtesy of Flinders University)

Superior Orthopedic Implants Combat Infections and Quicken Healing After Surgery

Implant-associated infections remain one of the biggest challenges in orthopedic surgery, leading to device failure, prolonged recovery, and increased antibiotic resistance. Conventional implant materials... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more